Isotretinoin and birth control

As the iPLEDGE program rolls in, perhaps the most important feature is the monitoring of pregnancy in women of childbearing potential both during isotretinoin therapy and for 1 month after treatment is complete. Starting in March, all women of childbearing potential will be required to register with the iPLEDGE program, answer questions about birth control, and enter the two forms of birth control that they are using. In addition, all women of childbearing potential will have to login to the iPLEDGE system every month to again answer questions and cofirm the two forms of birth control they are using.

Add comment January 9th, 2006